Business & Industry

Billerud has officially introduced PharmaKraft, a specialized fibre-based packaging material carefully designed for non-sterile dry pharmaceutical applications. This newly developed product utilizes fresh fibre featuring tightly controlled purity characteristics to meet rigorous industry demands. As a notable addition to...

AstraZeneca has inked a billion-dollar AI drug discovery partnership and licensing deal with insitro to identify novel targets and therapies for a range of cardiometabolic diseases. Through this strategic agreement, the organizations will work in tandem to create drugs...

In a significant step for pharmaceutical research, Danaher has announced plans to launch its first AI-powered autonomous research facility. Expected to become fully operational in early 2027 at the Abcam headquarters in Cambridge, UK, the upcoming AI autonomous lab...

The United States government, alongside technology enterprises Meta Platforms and Alphabet, is officially joining forces with the nonprofit organization Biohub. This collaborative effort aims to construct comprehensive open datasets designed to train advanced AI models for biological research, elevating...

India’s weight-loss drug story has moved well beyond a niche pharmaceutical category. GLP-1 medicines are now creating a rapidly expanding business around obesity and metabolic health, with Mounjaro and semaglutide at the centre of the competition. India’s GLP-1 segment reached...

Hengrui Pharma has entered into a licensing agreement with Novo Nordisk for HRS-1596, a phase I-ready glucagon-like peptide-1 receptor (GLP-1R) and gastric inhibitory polypeptide receptor (GIPR) dual agonist with potential for once-weekly oral dosing, in a deal valued at...

The Trump administration has released detailed guidance regarding specialty pharmaceutical tariff exemptions for products including orphan treatments, nuclear medicines, cell and gene therapies, and antibody-drug conjugates (ADCs). Effective September 29, 2026, these rules allow specific drug classes to enter...